This meeting is supported by Novartis and Abraxis.

Faculty

Professor Shou-Ching Tang, USA Professor Binghe Xu, China Co-Chairs

Invited faculty includes:
INTERNATIONAL Shou-Ching Tang, USA William Gradishar, USA Joyce O’Shaughnessy, USA Edith Perez, USA
ASIAN Binghe Xu, China Luis Chow, Hong Kong Mingfeng Ho, Taiwan Zefei Jiang, China Meijin Liu, Taiwan Zhiming Shao, China Kunwei Shen, China Yan Sun, China Jiong Wu, China Zihao Yu, China Baoning Zhang, China

During this interactive meeting leaders in the field will discuss with the participants clinical issues encountered in practice and address practical issues pertaining to Breast Cancer treatment in China.

Preliminary Topics include:

• Breast Cancer Epidemiology in China
• Advances in adjuvant chemotherapy
• Update in adjuvant hormonal therapy
• Adjuvant radiation therapy,the Chinese approach
• Hormonal therapy in MBC
• Chemotherapy in MBC: Is there a standard?
• Neoadjuvant therapy in locally advanced breast cancer
• Screening and chemoprevention in China
• Prognostic and predictive markers in breast cancer
• Targeting EGFR in breast cancer
• Angiogenesis inhibitors in breast cancer
• Novel taxanes in breast cancer
• Bisphosphonates in breast cancer
• Current clinical trials in China and Taiwan
• Breast cancer clinical trials in Europe and the US
• Challenges of clinical trials in China

This meeting is co-hosted by prIME Oncology (Professional Independet Medicial Education), USA and the Chinese Academy of Medical Sciences Cancer Institute and Hospital.

Click here for more information